Month: April 2021
This guidance document is part 1of our series Protection without pollution: COVID-19 waste-reduction strategies. These three guides will help health systems, hospitals, and other health care providers set up successful immunization programs that protect the health of people and our planet.
Gloves are the highest-volume disposable product purchased by health care, and glove use has increased dramatically and is expected to nearly double in the next five years. Our recommendations will help you purchase sustainable alternatives that meet environmental, health, and labor standards without compromising patient safety or care. As health care facilities rethink their purchasing and supply chains in the wake of COVID-19, this guidance can serve as a roadmap for advancing sustainable options.
Image: Clay Banks | Unsplash
The world is undertaking the largest immunization campaign in history to fight COVID-19. Billions will be vaccinated in the coming years, which is generating an unprecedented amount of waste. If we plan ahead, we can minimize the impact and waste while ensuring universal immunization.
The task ahead of us is huge. Innovative practices can reduce overall waste and provide a framework for safely processing hazardous materials. Medical waste must not be incinerated or dumped in landfills, it needs to be treated to reduce its impact on the environment and human health.
Health Care Without Harm is offering three guides to set up successful immunization programs that protect the health of people and our planet.
April 29, 2021
At least one child has been killed and others have been injured beneath the machines, as have some pets, the Consumer Product Safety Commission said. The commission considers the product “a serious risk to children for abrasions, fractures and death.”Read More
With vaccinations reaching more and more arms, families and friends are safely reuniting after a year or more apart. Most reunions are filled with the joy, but there’s also concern and anxiety, especially leading up to the events.Read More
The panel said benefits outweigh the risks, but a new FDA warning will say women under 50 should be made aware of higher risk for a rare clotting disorder and should be able to choose their vaccineRead More